Physician profile
Aravind Pothineni
NPI 1124215124
$17,562.48
in general payments reported to CMS, 2019-2025
37 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $1,751 · 2021: $1,338 · 2022: $1,385 · 2023: $9,679 · 2024: $1,477 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,258 · Food and Beverage: $4,467 · Travel and Lodging: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,257.85 |
| Food and Beverage | $4,466.99 |
| Travel and Lodging | $1,731.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,211.41 | 2023-2024 | Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals LP | $1,997.87 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,654.37 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Pulmonx Corporation | $897.63 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $696.45 | 2019-2024 | Ofev, Jardiance |
| Regeneron Healthcare Solutions, INC. | $624.35 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $584.87 | 2020-2025 | |
| Mylan Specialty L.P. | $403.13 | 2021-2024 | Yupelri, Yupelri |
| Actelion Pharmaceuticals US, INC. | $350.16 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| United Therapeutics Corporation | $311.93 | 2021-2024 | Tyvaso |
| Grifols USA, LLC | $291.73 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $257.92 | 2022-2025 | Arikayce |
| Genzyme Corporation | $187.75 | 2019-2025 | |
| Harmony Biosciences LLC | $181.17 | 2022-2024 | |
| Livanova USA, INC. | $108.12 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $97.34 | 2021-2025 | Tezspire, Repatha |
| Alexion Pharmaceuticals, INC. | $93.91 | 2019 | |
| Merck Sharp & Dohme LLC | $92.89 | 2020-2025 | Winrevair, Verquvo |
| Ethicon INC. | $68.53 | 2020-2025 | Monarch Platform |
| Novartis Pharmaceuticals Corporation | $48.20 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $46.10 | 2020 | |
| Eisai INC. | $41.85 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $39.97 | 2023 | Acthar |
| Cvrx, INC. | $33.97 | 2024 | Barostim Neo System |
| Elutia, INC. | $31.90 | 2021 | |
| Apria Healthcare LLC | $25.24 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.92 | 2021 | |
| Cardiva Medical, INC. | $20.38 | 2023 | Cardiva Vascade 6/7f Vcs |
| Inspire Medical Systems, INC. | $19.17 | 2023 | Inspire |
| Verona Pharma, INC. | $17.93 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $17.35 | 2025 | Yupelri |
| Pfizer INC. | $17.29 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.23 | 2021 | |
| Axsome Therapeutics, INC. | $14.64 | 2025 | Sunosi |
| Olympus America INC. | $14.58 | 2025 | |
| Electromed, INC. | $14.13 | 2023 | Smartvest |
| Janssen Pharmaceuticals, INC | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aravind Pothineni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.